Altered expression of the prion gene in rat astrocyte and neuron cultures treated with prion peptide 106-126

Cellular and Molecular Neurobiology

Volumn 25, Issue 8, 2005, Pages 1171-1183

  Ning, Zhang Yong ^a   Zhao, De Ming ^a   Liu, Hong Xiang ^b   Yang, Jian Min ^a   Han, Cai Xia ^a   Cui, Ya Li ^a   Meng, Li Ping ^a   Wu, Chang De ^a   Liu, Mei Li ^a   Zhang, Tai Xiang ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cultured astrocytes and neurons; mRNA expression; Prio npeptide 106 126; Real time RT PCR

Indexed keywords

MESSENGER RNA; NITROBLUE TETRAZOLIUM; PEPTIDE; PRION PEPTIDE [106-126]; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTOSIS; CELL DEATH; CELL PROLIFERATION; CEREBELLUM DEGENERATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FEMALE; GRANULE CELL; NERVE CELL CULTURE; NERVE CELL DEGENERATION; NEUROTOXICITY; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; ASTROCYTES; CELL PROLIFERATION; CELLS, CULTURED; CEREBELLAR CORTEX; CEREBRAL CORTEX; COCULTURE TECHNIQUES; DOWN-REGULATION; GENE EXPRESSION REGULATION; GLIOSIS; NERVE DEGENERATION; NEURONS; NEUROTOXINS; PEPTIDE FRAGMENTS; PRION DISEASES; PRIONS; PRPC PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

ANIMALIA;

EID: 29844439160     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-005-8357-5     Document Type: Article

References (32)

1. Blattler, T., Brandner, S., Raeber, A. J., Klein, M. A., Voigtlander, T., Weissmann, C., and Aguzzi, A. (1997). PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 389:69-73.
2. Brown, D. R. (1999a). Prion protein peptide neurotoxicity can be mediated by astrocytes. J. Neurochem. 73(3):1105-1113.
3. Brown, D. R. (1999b). Neurons depend on astrocytes in a coculture system for protection from glutamate toxicity. Mol Cell. Neurosci. 13(5):379-389.
4. Brown, D. R. (2000). PrPSc-like prion protein peptide inhibits the function of cellular prion protein. Biochem. J. 352:511-518.
5. Brown, D. R. (2001). Prion and prejudice: Normal protein and the synapse. Trends Neurosci. 24(2):85-90.
6. Brown, D. R., and Mohn, C. M. (1999). Astrocytic glutamate uptake and prion protein expression. Glia 25(3):282-292.
7. Brown, D. R., Schmidt, B., and Kretzschmar, H. A. (1996). Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 380:345-347.
8. Bruce, M. E., McBride, P. A., and Farquhar, C. F. (1989). Precise targeting of the sialoglyco-protein PrP and vacuolar degeneration in mouse scrapie. Neurosci. Lett. 102(1):1-6.
9. Chabry, J., Ratsimanohatra, C., Sponne, I., Elena, P. P., Vincent, J. P., and Pillot, T. (2003). In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression. J. Neurosci. 23:462-469.
10. Chen, S. G., Teplow, D. B., Parchi, P., Teller, J. K., Gambetti, P., and Autilio-Gambetti, L. (1995). Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem. 270(32):19173-19180.
11. Chiesa, R., and Harris, D. A. (2001). Prion diseases: What is the neurotoxic molecule? Neurobiol. Dis. 8(5):743-763.
12. Collinge, J. (2001). Prion diseases of humans and animals: Their causes and molecular basis. Annu. Rev. Neurosci. 24:519-550.
13. DeArmond, S. J., Mobley, W. C., DeMott, D. L., Barry, R. A., Beckstead, J. H., and Prusiner, S. B. (1987). Changes in the localization of brain prion proteins during scrapie infection. Neurology 37(8):1271-1280.
14. Diedrich, J. F., Bendheim, P. E., Kim, Y. S., Carp, R. I., and Haase, A. T. (1991). Scrapie-associated prion protein accumulates in astrocytes during scrapie infection. Proc. Natl Acad. Sci. U.S.A. 88(2):375-379.
15. Ettaiche, M., Pichot, R., Vincent, J. P., and Chabry, J. (2000). In vivo cytotoxicity of the prion protein fragment 106-126. J. Biol Chem. 275(47):36487-36490.
16. Fioriti, L., Quagliom, E., Massignan, T., Colombo, L., Stewart, R. S., Salmona, M., Harris, D. A., Forloni, G., and Chiesa, R. (2005). The neurotoxicity of prion protein (PrP) peptide 106-126 is independent of the expression level of PrP and is not mediated by abnormal PrP species. Mol. Cell. Neurosci. 28(1):165-176.
17. Florio, T., Thellung, S., Amico, C., Robello, M., Salmona, M., Bugiani, O., Tagliavini, F., Forloni, G., and Schettini, G. (1998). Prion protein fragment 106-126 induces apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in the GH3 cell line. J. Neurosci. Res. 54(3):341-352.
18. Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugiani, O., and Tagliavini, F. (1993). Neurotoxicity of a prion protein fragment. Nature 362:543-546.
19. Forloni, G., Del, B. R., Angeretti, N., Chiesa, R., Smiroldo, S., Doni, R., Ghibaudi, E., Salmona, M., Porro, M., Verga, L., Giaccone, G., Bugiani, O., and Tagliavini, F. (1994). A neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy. Eur. J. Neurosci. 6(9):1415-1422.
20. Freshney, R. I. (1987). Culture of specific cell types. In Freshney, R. I. (ed.). Culture of Animal Cells: A Manual of Basic Technique, AR Liss, New York, pp. 257-288.
21. Glatzel, M., and Aguzzi, A. (2000). PrP(C) expression in the peripheral nervous system is a determinant of prion neuroinvasion. J. Gen. Virol. 81:2813-2821.
22. Gu, Y., Fujioka, H., Mishra, R. S., Li, R., and Singh, N. (2002). Prion peptide 106-126 modulates the aggregation of cellular prion protein and induces the synthesis of potentially neurotoxic transmembrane PrP. J. Biol. Chem. 277:2275-2286.
23. Hope, J., Shearman, M. S., Baxter, H. C., Chong, A., Kelly, S. M., and Price, N. C. (1996). Cytotoxicity of prion protein peptide (PrP106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, a beta 25-35. Neurodegeneration 5(1):1-11.
24. Levi, G., Aloisi, F., Ciotti, M. T., and Gallo, V. (1984). Autoradiographic localization and depolarization-induced release of acidic amino acids in differentiating cerebellar granule cell cultures. Brain Res. 290(1):77-86.
25. Liemann, S., and Glockshuber, R. (1998). Transmissible spongiform encephalopathies. Biochem. Biophys. Res. Commun. 250(2):187-193.
26. Prusiner, S. B. (1991). Molecular biology of prion diseases. Science 252:1515-1522.
27. Prusiner, S. B. (1992). Chemistry and biology of prions. Biochemistry 31(49):12277-12288.
28. Prusiner, S. B. (1998). Prions. Proc. Natl. Acad. Sci. U.S.A. 95(23):13363-13383.
29. Raeber, A. J., Race, R. E., Brandner, S., Priola, S. A., Sailer, A., Bessen, R. A., Mucke, L., Manson, J., Aguzzi, A., Oldstone, M. B., Weissmann, C., and Chesebro, B. (1997). Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J. 16(20):6057-6065.
30. Rymer, D. L., and Good, T. A. (2000). The role of prion peptide structure and aggregation in toxicity and membrane binding. J. Neurochem. 75(6):2536-2545.
31. Selvaggini, C., De Gioia, L., Cantu, L., Ghibaudi, E., Diomede, L., Passerini, F., Forloni, G., Bugiani, O., Tagliavini, F., and Salmona, M. (1993). Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem. Biophys. Res. Commun. 194(3):1380-1386.
32. Thellung, S., Florio, T., Villa, V., Corsaro, A., Arena, S., Amico, C., Robello, M., Salmona, M., Forloni, G., Bugiani, O., Tagliavini, F., and Schettini, G. (2000). Apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in rat cerebellar granule cells treated with the prion protein fragment 106-126. Neurobiol. Dis. 7(4):299-309.